COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean

Virtual Health Sciences Library

  • Home
  • Search
  • Knowledge Base
  • Get a journal indexed in the Index Medicus
  • MyVHSL
  1. Home
  2. IMEMR
  3. Search Result
  4. Cardiac toxicity in breast cancer patients

Cardiac toxicity in breast cancer patients

Authors

Ibrahim, N. Y.
Saad, E. S.
Cairo University ; , Kasr Al Ainy School of Medicine, Kasr Al Ainy Center of Clinical Oncology and Nuclear Medicine [NEMROCK] ; , Clinical Oncology Department ;

Gulf J. Oncol. 2014; (15): 49-55
GJO-Gulf Journal of Oncology [The]
Journal Country: Kuwait
P-ISSN: 2078-2101
Type of Publication: Randomized Controlled Trial
Category: Humans, Female,
Country of Research: Egypt WHO Eastern Mediterranean Region
Type of Research: Clinical
MeSH Terms: / Radiotherapy
Broad Subjects: Noncommunicable Diseases, Heart Diseases ,Chemically Induced ,Radiotherapy ,Adverse Effects ,Prospective Studies
Citation: N. Y. Ibrahim, E. S. Saad, Cardiac toxicity in breast cancer patients. Gulf J. Oncol. 2014; (15): 49-55

Abstract English

To asses cardiac toxicity post radiotherapy in left cancer breast patients with different fractionations. This is a prospective randomized study conducted at Kasr El-Ainy Center of Clinical Oncology and Nuclear Medicine [NEMROCK] . Cardiological assessment using RTOG toxicity criteria was done for left sided breast cancer patients after at least five years of conformal radiation therapy. There were two arms of radiation, conventional [50Gy/25sttt/5 Ws] and hypofractionation [42.5 Gy 716 fractions /3 1/5 weeks] . Thirty patients were included in each arm. After a median follow up of 62 months [range 60 to 72] , cardiac dysfunction developed more in the conventional arm but was insignificant [P value =0.36] . Grade I and II toxicity was 83.3 vs 70% and grade III was 3.3% in the hypofractionated arm only. The rate of local-regional tumor relapse at 5 years was similar [3.3%] . Hypofractionated radiotherapy decreased cardiac toxicity though not statistically significant, however it is more cost effective and time consuming

Request full text

Subscribe to VHSL Newsletters

© 2023 WHO – EMRO